ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
yolt
|
42 |
13K |
1 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
42
|
13K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
yolt
|
42 |
13K |
6 |
09/07/23 |
09/07/23 |
ASX - By Stock
|
42
|
13K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
yolt
|
42 |
13K |
8 |
08/07/23 |
08/07/23 |
ASX - By Stock
|
42
|
13K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
yolt
|
42 |
13K |
10 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
42
|
13K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
yolt
|
103 |
38K |
5 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
103
|
38K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
yolt
|
103 |
38K |
7 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
103
|
38K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Update and Corporate Presentation
|
|
yolt
|
27 |
7.9K |
6 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
27
|
7.9K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Mass Balance Paxalisib Trial
|
|
yolt
|
3 |
1.1K |
4 |
18/06/23 |
18/06/23 |
ASX - By Stock
|
3
|
1.1K
|
4
|
|
ASX - By Stock
|
KZA |
Mass Balance Paxalisib Trial
|
|
yolt
|
3 |
1.1K |
1 |
18/06/23 |
18/06/23 |
ASX - By Stock
|
3
|
1.1K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Launch of LUMOS2 Study
|
|
yolt
|
23 |
6.9K |
4 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
23
|
6.9K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Launch of LUMOS2 Study
|
|
yolt
|
23 |
6.9K |
9 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
23
|
6.9K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Launch of LUMOS2 Study
|
|
yolt
|
23 |
6.9K |
6 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
23
|
6.9K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Launch of LUMOS2 Study
|
|
yolt
|
23 |
6.9K |
12 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
23
|
6.9K
|
12
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Launch of LUMOS2 Study
|
|
yolt
|
23 |
6.9K |
3 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
23
|
6.9K
|
3
|
|